Dr. Vivian T. Yin is a clinical associate professor at the University of British Columbia specialized in ophthalmic plastic and reconstructive surgery. She worked at Memorial Sloan Kettering Cancer Center in New York and returned to Vancouver in 2019. After completing her medical degree and ophthalmology residency at the University of Toronto, she pursued a prestigious 2-year fellowship training in Ophthalmic Plastics and Reconstructive Surgery at the University of Texas M.D. Anderson Cancer Center in Houston, Texas. She focuses on the treatment of periocular and orbital disease, with the use of genetic-based targeted therapy as her research interest, and speaks internationally on these topics. She is also a clinical trial investigator for multiple therapeutics in development for the treatment of thyroid eye disease.
Financial disclosure: Dr. Yin has/had an affiliation (financial or otherwise) with a commercial organization:
- Sling Therapeutics - Co-PI
- Amgen - Consultant and Co-PI
- AbCellar, Kriya - Consultant
- Viridian - Clinical Trial PI
Sessions in which Vivian Yin MD, MPH participates
Thursday 24 June, 2021
Access the Live Meeting: https://www.yourconference.live/COS
Friday 25 June, 2021
Question 1: What area of oculoplastic surgery is most in need of innovation? Question 2: What has been the most impactful development/paper in Oculoplastics in the past few years? Question 3: What lasting impact will COVID-19 have on your practice? Question 4: What strategies do you use to continue to develop and stay on top of your game?
Sunday 27 June, 2021
Learning ObjectivesAt the end of this session, participants will be able to: List key issues in managing patients with glaucoma and corneal transplantsDescribe the “Value Proposition” of glaucoma management from the Patient’s PerspectiveReview vision screening options for stroke admissions through the pathway from emergency department to dischargeDescribe the ocular manifestation of Zika and Ebola infe...